Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse
5
Articles
9289
Views

Author Profile

Ross Drew

 

The Countdown to October 16 Begins for Vringo and Google
08/20/2012 - 12:45pm
There are less than two months left until Vringo (NYSE: VRNG) and Google (NASDAQ: GOOG) go head-to-head in court.
In-Depth Look at ChromaDex and Its Clinical Results
06/13/2012 - 5:41pm
ChromaDex (OTC: CDXC) released positive clinical safety data today on its flagship ingredient, pTeroPure. ChromaDex is traded on the over-the-counter markets and saw heavy volume following the news, despite closing the session unchanged in price.
ChromaDex's Nicotinamide Riboside Discussed in 'Cell Metabolism'
06/06/2012 - 4:39pm
June 6, 2012 - Cell Press:
Vivus' Qnexa Is Not Guaranteed Approval. Remember Provenge?
05/31/2012 - 12:52pm
Dear Vivus (NASDAQ: VVUS) investors: You are paying $2.5 billion for a company with zero profits in a market space valued at only $3.5 billion annually.
Meat Glue Harbors Rogue Diseases, Government Fails to Intervene
05/29/2012 - 8:30am
It should come as no surprise that our government is yet again neglecting the food supply. The U.S.

Get Benzinga's News Delivered Free

Benzinga Professional

Subscribe